Covid-19
Conditions
Keywords
ambulatory, outpatients, COVID 19, Oise, France
Brief summary
Since December 2019, a new agent, the coronavirus SARS-Cov-2, has spread from China to the rest of the world causing an international epidemic of respiratory diseases called COVID-19. Oise was one of the first clusters in France, with more than 4,000 confirmed cases. A significant proportion (80%) of patients with COVID-19 are ambulatory. However, few data are available for this particular population in France. Thus, few clear recommendations are available. We propose to conduct a large cohort of observation of suspected or confirmed COVID-19 patients on an ambulatory basis in the Oise region. This observatory will make it possible to describe the epidemiological characteristics and initial management of COVID-19 patients and to identify early severity factors.
Interventions
observational management of outpatients COVID 19
Sponsors
Study design
Eligibility
Inclusion criteria
* patients with covid 19 symptoms * patients who had a contact with a person PCR Covid 19+
Exclusion criteria
* none
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| clinical description of covid 19 ambulatory cases. | 3 months |
Secondary
| Measure | Time frame |
|---|---|
| Biological and radiological description of ambulatory cases | 3 months |
| Prevalence of positive cases (PCR and/or serological positive) | 3 months |
Countries
France